STEVEN RAMM: Open Payments
NPI 1801876628 · NEW WINDSOR, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,390 in 142 payments from 23 companies in 2025. Trend: 2023 $2,915 · 2024 $3,270 · 2025 $3,390
Food & beverage: $3,390
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 27 | $721 |
| ABBVIE INC. | 24 | $444 |
| Lilly USA, LLC | 16 | $417 |
| PFIZER INC. | 12 | $252 |
| Novo Nordisk Inc | 7 | $236 |
| Otsuka America Pharmaceutical, Inc. | 11 | $210 |
| Abbott Laboratories | 4 | $189 |
| GlaxoSmithKline, LLC. | 6 | $146 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $123 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $108 |
Products named: BREZTRI, VRAYLAR, JARDIANCE, REXULTI, FREESTYLE LIBRE, AIRSUPRA, Ozempic, FARXIGA.
Industry payments across NY — which companies pay providers there.
